202 results
DEFM14A
INFIQ
Infinity Pharmaceuticals, Inc.
6 Jun 23
Proxy related to merger
4:31pm
when, if ever, it will become profitable. Unused net operating loss and tax credit carryforwards will carry forward to offset future taxable income … . Federal net operating losses incurred in taxable years ending after December 31, 2017, are eligible to be carried forward indefinitely, but may offset
8-K
EX-99.1
INFIQ
Infinity Pharmaceuticals, Inc.
3 May 22
Infinity Pharmaceuticals Reports First Quarter 2022 Financial Results
4:07pm
to an increase in compensation expense due primarily to new hires during the period, partially offset by a decrease in clinical development expenses … million for the same period in 2021. The increase in G&A expense is primarily due to an increase in stock compensation, partially offset by a decrease
424B5
hqtn1z54
12 Feb 21
Prospectus supplement for primary offering
4:40pm
424B5
fofo6m9s6z5au75bjbef
11 Feb 21
Prospectus supplement for primary offering
4:06pm
DEFA14A
4ci3etst 5qf4scxan
4 Jun 20
Additional proxy soliciting materials
8:40am